Alphabet's AI-drug development could be a big tailwind, says Big Technology’s Alex Kantrowitz

CNBC Television 21,501 7 hours ago

Video Not Working? Fix It Now

CNBC’s Deirdre Bosa, Big Technology’s Alex Kantrowitz and Wealth Enhancement’s Ayako Yoshioka, join 'Closing Bell' to discuss Alphabet ahead of its earnings

Comment